Removal of middle molecules with medium cutoff dialyzer in patients on short frequent hemodialysis.
Thiago ReisFrancesca MartinoPriscila DiasGeraldo R R de FreitasEvandro R da Silva FilhoMaria L C de AzevedoFábio ReisMario CozzolinoLilia Rizo-TopeteClaudio RoncoPublished in: Hemodialysis international. International Symposium on Home Hemodialysis (2020)
In this retrospective analysis, short frequent MCO-HD promotes a reduction in prolactin, a middle weight uremic toxin, and trends toward a reduction in α1-acid glycoprotein. No patients developed hypoalbuminemia. These findings are encouraging and deserve investigation in prospective studies.